Plasma Lipid Profiling for Risk Assessment of Unstable Coronary Artery Disease

用于不稳定冠状动脉疾病风险评估的血浆脂质分析

• 批准号: nhmrc : 1038631
• 负责人: Dr Brita Pekarsky
• 金额: $ 34.16万
• 依托单位: Baker IDI Heart and Diabetes Institute
• 依托单位国家: 澳大利亚
• 项目类别: Development Grants
• 财政年份: 2012
• 资助国家: 澳大利亚
• 起止时间: 2012-01-01 至 2014-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/plasma-lipid-profiling-artery-disease/111194
• 关键词: Plasma; Lipid; Profiling; Risk; Assessment

Age, sex, smoking, blood pressure and cholesterol level are risk factors for the development of heart disease. Most adults belong to an intermediate-risk group in which the predictive power of current risk factors is low. Most heart attacks occur in this group. Consequently, many individuals at risk are not properly identified nor treated appropriately. We are developing a new test to accurately assess risk of a future heart attack that will address this deficiency in our health system.

年龄、性别、吸烟、血压和胆固醇水平是心脏病发生的危险因素。大多数成年人属于中危人群，当前危险因素的预测能力较低。大多数心脏病发作都发生在这一群体中。因此，许多面临风险的个人没有得到适当的识别或适当的治疗。我们正在开发一种新的测试，以准确评估未来心脏病发作的风险，从而解决我们卫生系统中的这一缺陷。